Steering Committee

THE MAIN ROLES OF THE COMMITTEE MEMBERS ARE TO:

BRING SUPPORT

to MedFIT organisers in defining the positioning and the objectives of the event

STEER

the content of the conference programme

HELP IDENTIFY

appropriate, high-level speakers

PROMOTE

the event to their networks

Edit Content
Beatriz Volckaert

Beatriz Volckaert

Senior Associate
The NetherlandsPhilips Ventures

Experienced healthcare investment professional with expertise in early-stage start-up investment. Currently involved in deal sourcing, investment diligence, and portfolio management of European digital health companies at Philips Ventures.

Beatriz Volckaert

Senior Associate
The NetherlandsPhilips Ventures
Cécile Théard-Jallu

Cécile Théard-Jallu

Partner Attorney
FranceDe Gaulle Fleurance & Associés

Cécile Théard-Jallu has developped in-depth expertise as an attorney in private practice representing multinational corporations, including major US and European firms and public and private organizations in the life sciences and innovation sectors. Cecile focuses primarily on complex transactions including R&D and consortiums, technology transfers, licensing deals other technological change related projects. She assists clients with their responses to calls for projects in the R&D and innovation sector in the context of public funding. She also advises them on the design, negotiation and enforcement of their commercial or IT contracts.

She worked in a leading law firm in Washington DC as an attorney in private practice on secondment and was also seconded to a global player in the medical equipment sector. She regularly lectures on research and innovation law and is a member of the International Bar Association in the life sciences practice.

Cécile Théard-Jallu

Partner Attorney
FranceDe Gaulle Fleurance & Associés
Daniel O’Mahony

Daniel O’Mahony

Partner
IrelandSeroba Life Sciences

Daniel O’Mahony is a Partner at Seroba Life Sciences venture capital fund and brings a wealth of experience from pharma and medtech industry in product development, strategic planning, licensing, corporate venturing, technology commercialisation and venture capital investment. Daniel graduated with a Ph.D. from University College Cork, holds a business degree in technology management from the Smurfit Business School and has held academic appointments in Ireland and USA. He currently sits on a number of boards include Atlantic Therapeutics, Perfuze and ATXA Therapeutics.  He previously sat on the boards of PQ Bypass (acquired by Endologix), Novate Medical (acquired by BTG), Apica Cardiovascular (acquired by Thoratec), Covagen (acquired by Janssen), Stokes Bio (acquired by Life Technologies), Straatum (acquired by Lam Research Corporation).

Daniel O’Mahony

Partner
IrelandSeroba Life Sciences
David Aubert

David Aubert

MEDTEG Business Developer
BelgiumGhent University

David Aubert holds an MBA from the Erasmus University Rotterdam School of Management and is responsible for the medical technology valorization at the Ghent University (MEDTEG). Prior to that, he has built a +25y international experience responsible for various businesses within large corporations such as Philips Health Tech.

David Aubert

MEDTEG Business Developer
BelgiumGhent University
Franz Bozsak

Franz Bozsak

CEO & Co-Founder
FranceSensome

Franz obtained a M.S. in Aerospace Engineering from the University of Stuttgart and a Ph.D. from Ecole polytechnique in Biomedical Engineering on the optimization of stents. He is a graduate of the Stanford Ignite/Polytechnique business program. In 2014, he co-founded Sensome and has since brought together a team of renowned scientists, engineers and doctors to realize his vision of connected medical devices. He was named Innovator Under 35 by the MIT Technology Review in 2016.

Franz Bozsak

CEO & Co-Founder
FranceSensome
Mike Karim

Mike Karim

CEO
United KingdomOxford Endovascular

Mike is the CEO and co-founder of Oxford Endovascular Ltd, a spinout from Oxford University.

The company is developing a revolutionary medical device for patients suffering from brain aneurysms; a life-threatening disease affecting 1 in 50 persons in a strongly growing market valued over $1 billion . In 2017 it won ‘Best Med-Tech Start-Up’ at the Oxford Bio Network awards, 1st place at the BioTrinity ‘Perfect Pitch’ competition and an award at the ‘European Health Catapult’ finals.

Mike has 27 years growing international businesses in large corporations & start-ups.

Experienced in strategic planning, execution, team building, gaining regulatory approvals & fund raising.

Mike mentors students and presents at industry conferences. He studied Pre-Clinical Medicine, Physiology & Pharmacology at Southampton University and an MBA from Henley Business School.

Mike Karim

CEO
United KingdomOxford Endovascular
Nicolas Ploquin

Nicolas Ploquin

CEO
FranceUnilabs

Nicolas Ploquin is an Area General Manager VP for Western European Markets at Johnson & Johnson, who leads the business strategy and organization of the diabetes care business throughout Russia, Central Europe and Middle-East Africa. After spending nearly 15 years working in general management for medical devices ranging from contact lenses, blood glucose devices, surgical instruments to 3D-maping cardiovascular devices in Turkey, Latin America, Europe and Middle-East and Africa, Nicolas knows what truly drives medical devices commercial and market access strategies in emerging and developed markets—while building sustainable organization and successful teams. He is passionate about introducing cutting-edge health-care innovation and leading and adapting commercial model and organization to an ever-changing socio-economic environment while responding to the need of the payer, doctors and patient environment.

Nicolas has started his career in marketing and brand management in France at major consumer and luxury goods companies such as Unilever, Nestlé, Havas and LVMH.

Nicolas holds a MSc of EDHEC Business School and a MBA from Harvard University, Massachusetts and leaves currently at Zurich in Switzerland.

Nicolas Ploquin

CEO
FranceUnilabs
Ravi Chana

Ravi Chana

Head of Business Development
United KingdomRoche Diagnostics

After completing a degree in Pharmacology, Ravi gained employment in non-health and health related sectors, undertaking Sales, Marketing, Market Access, Business Development and Health Economics roles. Prior to re-joining Roche Diagnostics Ravi undertook projects for the UK Department of Health and also for the UK Department for International Trade. A major area of focus within these roles was to assist HealthTech innovators (SMEs and Large organisations) gain access to the most appropriate experts in UK Universities and the NHS. He has also been part of various working groups within the National Institute of Health and Clinical Excellence (NICE), National Institute for Health Research (NIHR), the British In-Vitro Diagnostics Association (BIVDA) and Association of British Healthtech Industries (ABHI).

Ravi’s current role as Head of Business Development is focused on assessing innovative technologies which could fit the Roche Diagnostics portfolio or bit useful for the UK affiliate to work with across patient care pathways. Areas of particular focus are Cardiac Disease, Oncology, Women’s Health, Alzheimer’s and Infectious Diseases, with Digital Health as a cross cutting theme of interest. The role also allows Ravi to work closely with the Roche Global Business Development team to bring any potential technologies to the Roche global organisation to assess.

Ravi Chana

Head of Business Development
United KingdomRoche Diagnostics
Rogier Receveur

Rogier Receveur

Senior Program Manager Innovation and New Business Generation
The NetherlandsMedtronic Bakken Research Center

Rogier Receveur

Senior Program Manager Innovation and New Business Generation
The NetherlandsMedtronic Bakken Research Center
Ulf Hengstmann

Ulf Hengstmann

Digital Lead Medical Affairs & Pharmacovigilance
GermanyBayer

Addicted to Digital Transformation with 30 years of experience in Biology, Genomics, Market Intelligence, IT-Portfolio-, Product-, Program-, Project- and  Line-Management.

Ulf got his PhD in microbiology and genomics at the Max-Planck-Institute for terrestrial Microbiology Marburg. After postdoc awardee his business stations were the Georg Thieme Verlag, Stuttgart and the Bertelsmann AG (Lycos Europe GmbH) before he joined Bayer in 2002. From 2015 he has been Digital Innovation Manager, supporting Bayer’s path in Digital Transformation, since 2019 he is Business Partner for Medical Affairs and Pharmacovigilance. Current projects are Proof of Concept in quantum computing and the implementation of a non-interventional study for the mobile detection of atrial fibrillation. He enjoys mountain- and racing-biking, soccer and guitar playing.

……..Innovation is just a thought away………

Ulf Hengstmann

Digital Lead Medical Affairs & Pharmacovigilance
GermanyBayer
Vassilis Georgiadis

Vassilis Georgiadis

Principal Partnerships Manager (Pharma & Healthcare)
United KingdomUCL Innovation and Enterprise

Vassilis Georgiadis

Principal Partnerships Manager (Pharma & Healthcare)
United KingdomUCL Innovation and Enterprise
Xavier Bertrand

Xavier Bertrand

Vice President EMEA Healthcare Services & Alliances
FranceBoston Scientific

Xavier Bertrand is currently Vice President EMEA Healthcare Services & Alliances for Boston Scientific, a global leader in medical devices. He leads Hospital Solutions efforts, Capital Equipment programs, Digital Health and Business Development activities in EMEA. Prior to this role, Xavier was Global VP&GM Symetis, a Swiss TAVI leader acquired by Boston Scientific, leading all activities from R&D, Manufacturing to Commercial execution. He was previously Vice President, Europe Interventional Cardiology & Structural Heart. Prior to Boston, he managed the European structural heart business at Medtronic, and also served in smaller size companies like ATS Medical as General Manager EMEA or Biosensors International as VP Global Marketing. He started his career as SAP and change management consultant at Price Waterhouse Coopers, a global consulting firm.

Xavier Bertrand

Vice President EMEA Healthcare Services & Alliances
FranceBoston Scientific
Edit Content
Rogier Receveur

Rogier Receveur

Senior Program Manager Innovation and New Business Generation
The NetherlandsMedtronic Bakken Research Center

Rogier Receveur

Senior Program Manager Innovation and New Business Generation
The NetherlandsMedtronic Bakken Research Center
Edit Content
Edit Content
Vassilis Georgiadis

Vassilis Georgiadis

Principal Partnerships Manager (Pharma & Healthcare)
United KingdomUCL Innovation and Enterprise

Vassilis Georgiadis

Principal Partnerships Manager (Pharma & Healthcare)
United KingdomUCL Innovation and Enterprise
Edit Content

Continue your tour

Contact

Marion Loizurot

  • No products in the cart.